← SynDRA
BAY-1161909
SynDRA canonical compound SYN0039843 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | TTK |
|---|
| Mechanism of action | protein kinase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- TTK INHIBITOR
- Dual specificity protein kinase TTK inhibitor
- protein kinase inhibitor
Cross-references
Synonyms
- BAY 1161909
- EMPESERTIB
- (-)-BAY-1161909
- 8QW
- BAY1161909
- CPD 41
- MPS1-IN-5
- Empesertib
- Empesertib [INN]
- Empesertib [WHO-DD]
- UNII-02Y3Z2756M
- empesertibum
- RefChem:136715
- BAY116-1909
- Mps1-IN-5
- Empesertib [INN:WHO-DD]
- C29H26FN5O4S
- GTPL9427
- orb1298892
- SCHEMBL15036597
- SCHEMBL29446169
- NRJKIOCCERLIDG-GOSISDBHSA-N
- BDBM329334
- GLXC-10349
- EX-A3543
- BAY1161909;Mps1-IN-5
- MFCD28902188
- NSC787025
- AKOS028109757
- CS-4887
- EBC-419046
- NSC-787025
- US9663510, Example 01.01
- NCGC00488781-01
- AC-36445
- AS-82506
- BB177693
- DA-61505
- HY-12858
- T8487
Look up BAY-1161909 in the interactive SynDRA portal →